Skip to Main Content

Paper Details

Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas.
Clin Cancer Res
11
2022
AMP, AMP-activated kinase, CDX, DNA, Gamitrinib, Gliomas, HSP90, Neurospheres, PDO, RNA, TMZ, TMZ-resistant glioma cell lines, antitumor, cell line-derived xenografts, glioma, glioma cells, gliomas, human, mice, neurospheres, patient, primary glioma cell lines, temozolomide, temozolomide (TMZ)-resistant human glioma cell lines, tumor, tumors
Author NameAffiliation
Stephen T KeirDuke University Medical Center
Stephen T KeirDuke University School of Medicine
Yiling LuThe University of Texas MD Anderson Cancer Center
Gordon B MillsKnight Cancer Institute, Oregon Health Sciences University
Gordon B MillsKnight Cancer Institute, Oregon Health Sciences University
Meenhard HerlynThe Wistar Institute
Zhi WeiYing Wu College of Computing, New Jersey Institute of Technology
Gao ZhangDuke University Medical Center
Gao ZhangDuke University School of Medicine
Gao ZhangDuke University School of Medicine
  • 1 - 10

Datasets

Release 1.2